Satish K. Tyagi, Senior Director, is a Principal and Founder in KBT Partners. He was a Principal in Delta Capital & Research, LLC (DC&R), based in Boston. DC&R provides financial advisory and strategic consulting services for start-up and growth companies in the healthcare information and medical technology field. Typical engagements include seed capital and private placement support, product line analysis, market research, and operations management in conjunction with financing strategy, partnering and M&A counsel. Mr. Tyagi takes an active role in DC&R's venture capital portfolio of 12 start-ups, and was instrumental in the sale of The PenChart Corp., an EMR vendor, to Pfizer Inc.

Mr. Tyagi was also engaged with Schroder Venture Life Science Advisers Inc., an international venture capital firm dedicated to the health care industry, as a Venture Partner, and as an Advisor to Cornerstone Partners, a West-Coast based healthcare IT M&A boutique. He previously sat on the Board of publicly traded Superior Consultant Holdings Corp. Mr. Tyagi's career spans a decade as a Wall Street research analyst, with Punk, Ziegel and Knoell (where he pioneered investment coverage of healthcare information technology as a unique research sector), and Jefferies & Company and SG Cowen Securities Corp. Prior to joining Wall Street, he was a Senior Financial Analyst with The Sage Group. He began his career in Sales & Marketing in 1977 with India's IT pioneer, HCL.

Mr. Tyagi received his B.A. in Economics from the University of Delhi, a Post-Graduate Diploma in Marketing from the Indian Institute of Management, Calcutta, and M.B.A. in Finance from New York University.